PA005216-ANT-370: IL-16 Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB, ELISA;
Reactivity: Human;
Clone: PJ2F10AT;
Isotype: Mouse IgG1.BP000275-CHM-313: Recombinant Mouse MCP-1 (CCL2)
Source: E. coli-derived.
A single,non-glycosylated, polypeptide chain containing 125 amino acids and having a molecular mass of 14 kDa.
The biological activity was determined by calculating its ability to chemoattract Balb/C mouse spleen MNCs at 1.0-20.0 ug/ml.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000275-CHM-315: Recombinant Rat MCP-1 (CCL2)
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 125 amino acids and having a molecular mass of 14 kDa.
ED50 =1-10ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg. The biological activity was determined by measuring the dose dependent chemotaxis with human THP-1 cells. The optimal concentration should be determined for each specific application by an initial dose-response assay.
Purity > 95%, by SDS-PAGE.BP000276-CHM-316: Recombinant Human C-C Motif Chemokine 8 (CCL8) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 76 amino acids and having a molecular mass of 8904 Dalton.
The biological activity was determined by measuring the dose dependent mobilization of intracellular calcium (calcium flux) with human THP-1 cells. Significant calcium mobilization is observed with 500 ug/ml of recombinant human MCP-2. Human MCP-2 also induces dose dependent chemotaxis of human THP-1 cells with an ED50=30-100 ug/ml corresponding to a Specific Activity of 10,000-33,334 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000138-CYT-142: Recombinant Human Interleukin-16 (121 a.a.) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human CD4+ T-Lymphocytes using a concentration range of 50.0-100.0 ug/ml.
Purity: > 97.0% by RP-HPLC and SDS-PAGE.BP000276-CHM-355: Recombinant Mouse C-C Motif Chemokine 8 (CCL8) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 74 amino acids and having a molecular mass of 8507 Dalton.
Determined by its ability to chemoattract human peripheral blood monocytes using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000138-C045: Recombinant Human Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
The ED50 as determined by its ability to chemoattract human CD4+ T lymphocytes using a concentration range of 10.0-100.0 ug/ml, corresponding to a Specific Activity greater than 1.0 x 104 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000138-CYT-153: Recombinant Rhesus Macaque Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human CD4+ T-Lymphocytes using a concentration range of 50.0-100.0 ug/ml corresponding to a Specific Activity of 10,000-20,000 IU/mg.
Purity: > 98.0% by SDS-PAGE.BP000277-CHM-280: Recombinant Rat C-C Motif Chemokine 7 (CCL7) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human peripheral blood monocytes using a concentration range of 50.0-300.0 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000277-CHM-317: Recombinant Human C-C Motif Chemokine 7 (CCL7) Protein
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 76 amino acids and having a molecular mass of 9011 Dalton.
The specific activity as determined by the ability of MCP-3 to chemoattract human peripheral blood at 8 - 80 ug/ml corresponding to a Specific Activity of 12,500-125,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.